Transcriptional profiling identifies a gene program active in metastatic prostate cancers that failed to respond to enzalutamide treatment.

From a negative pressure helmet to enhanced protocols, investigators are adapting their research to focus on the COVID-19 pandemic.

Scientists have identified the binding pocket for molecules that can stabilize a key braking mechanism in cancer — opening the door to the development of drugs that target it.

U-M study combines local data with data from The Cancer Genome Atlas to discover novel biomarkers for chromophobe renal cell carcinoma through next-generation RNA sequencing.

U-M study offers new clues about how the composition of the gut microbiome may contribute to the development of colorectal cancer.

Improved outcomes in some patients could be due to a more complete reversal of the effects of muscle relaxants used during surgery.